Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Applied Genetic Technologies Corporation (AGTC : NSDQ)

• Company Description    Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. Applied Genetic Technologies Corporation is headquartered in Alachua, Florida. Number of Employees: 83

• Price / Volume Information    Yesterday's Closing Price: $0.88 Daily Weekly Monthly 20 Day Moving Average: 456,236 shares Shares Outstanding: 50.73 (millions) Market Capitalization: $44.78 (millions) Beta: 1.65 52 Week High: $4.65 52 Week Low: $0.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -14.31% -3.50% 12 Week -54.74% -50.24% Year To Date -53.55% -41.35%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 14193 NW 119TH TERRACE SUITE 10 - ALACHUA,FL 32615 USA ph: 386-462-2204 fax: - david.carey@finnpartners.com http://www.agtc.com

• General Corporate Information    Officers Susan B. Washer - Chief Executive Officer; President and Director Jonathan I. Lieber - Chief Financial Officer Gerald A. Reynolds - Chief Accounting Officer Scott Koenig - Director William Aliski - Director Peer Information Applied Genetic Technologies Corporation (CORR.) Applied Genetic Technologies Corporation (RSPI) Applied Genetic Technologies Corporation (CGXP) Applied Genetic Technologies Corporation (BGEN) Applied Genetic Technologies Corporation (GTBP) Applied Genetic Technologies Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 03820J100 SIC: 2836 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/22 Next Expected EPS Date: 09/22/22 Share - Related Items Shares Outstanding: 50.73 Most Recent Split Date: (:1) Beta: 1.65 Market Capitalization: $44.78 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.29 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.46 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/22/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.95 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 17.50% vs. Previous Quarter: 26.67% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -98.79 12/31/21 - -83.27 09/30/21 - -81.08 ROA 03/31/22 - -60.15 12/31/21 - -55.07 09/30/21 - -54.28 Current Ratio 03/31/22 - 2.73 12/31/21 - 3.13 09/30/21 - 4.30 Quick Ratio 03/31/22 - - 12/31/21 - 3.13 09/30/21 - 4.30 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - -12,945.20 12/31/21 - -13,058.00 09/30/21 - -12,319.80 Book Value 03/31/22 - 0.93 12/31/21 - 1.20 09/30/21 - 1.62 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.24 12/31/21 - 0.26 09/30/21 - 0.23 Debt-to-Capital 03/31/22 - 19.45 12/31/21 - 20.82 09/30/21 - 18.38

Powered by Zacks Investment Research ©